Anika’s manufacturing operations were previously split between its U.S. headquarters and an Italy-based contract manufacturer. But in a move to onshore manufacturing to the U.S., the company said it hopes to maintain better control of supply chain, speed up product development and increase operating efficiency.
By the end of 2017, the 134,000-square foot corporate headquarters and the newly-expanded facility will manufacture and package all of the company’s products.
“We are proud and excited to consolidate our entire manufacturing operation in the United States on the 25th anniversary of our inception,” president & CEO Charles Sherwood said in prepared remarks. “The new facility not only helps Anika more deftly manage global supply and inventory, but it also creates opportunities for a highly-skilled workforce, and brings sophisticated scientific capabilities and cutting-edge technologies back to the U.S. and to the state of Massachusetts, which has been a steadfast and supportive partner throughout our 25-year journey.”
Anika’s manufacturing plant and corporate headquarters employs approximately 100 professionals and the company said it is the only facility in the U.S. with the capability to produce hyaluronic acid products in solid textile forms.
“We welcome Anika Therapeutics’ decision to bring its healthcare manufacturing sector back to the U.S. and to the commonwealth as they celebrate 25 years supporting our local economy,” Massachusetts governor Charlie Baker said. “Our strong and talented workforce is helping businesses large and small thrive, supporting economic growth and new jobs across Massachusetts.”
“For 25 years Anika Therapeutics has provided value and stability to not just the life sciences industry, but the commonwealth as a whole. With this upcoming expansion, the anticipated and sustained impact on the local and state economy cannot be overstated,” Travis McCready, president & CEO of the Massachusetts Life Sciences Center added. “On behalf of the Massachusetts Life Sciences Center, I congratulate Anika on these first 25 years, and look forward to their continued success for the next quarter century and beyond, here in Massachusetts.”
“Congratulations to Anika and its leadership on celebrating 25 years of success and growth,” Robert Coughlin, CEO & president of MassBio, said. “Their longevity and commitment to innovation is a shining example for other Massachusetts companies who are looking to follow their lead.”